VALANX Biotech (VALANX), a biotech company developing novel technology for site-specific protein conjugation in drug ...

India must prioritize including the typhoid conjugate vaccine in its immunization program to combat the disease's high burden.

Conference Call and Webcast Presentation The FibroGen management team will host a conference call and webcast presentation to discuss the financial results and provide a business update. A live Q&A ...

A variety of vaccines in the U.S. childhood vaccination schedule help to protect kids against meningitis.

Rohit Batta CEO, Alethio Therapeutics Mike Grey Chair, Alethio Therapeutics Leveraging deep scientific and clinical expertise ...

Austrian biotech VALANX Biotech has appointed Klaus Orlinger as chief scientific officer, reinforcing its leadership as the ...

Beijing Tsingke Biotech Co., Ltd., a pioneer in molecular manufacturing, showcased its next-generation integrated ...

A rising wave of tumor-agnostic therapies were one of ESMO’s themes, highlighted during the opening press conference by Toni ...

An impartial and rigorous evaluation of the quality, efficacy and long-term safety of the specific vaccine being administered is essential. Failure to provide clear, public data risks generating fear ...

Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today ...

Beijing Tsingke Biotech Co., Ltd., a pioneer in molecular manufacturing, showcased its next-generation integrated platforms at the 2025 Festival ...

Lantern today announced it will present two commercially deployed AI research platforms at the inaugural AI for Biology and Medicine (AI4BM) symposium at the University of North Texas. The symposium, ...